Stocks · News reference

Context Therapeutics shares are trading lower after the company reported worse-than-expected Q2 EPS results.

Aug 6, 2026, 1:28 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 6, 2026, 8:55 AMAvi Kapoor
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
SiTime Corp (SITM) stock rose 30.7% in pre-market trading after beating earnings and sales estimates. Other gainers include CLRO, WYHG, SURG, PAVS, MGRX, CELZ, SOUN, WPP, HNST. YXT was the only loser after CFO resignation.
Read original at benzinga
AKBA CELZ CLRO CNTX FLNC
BenzingaAug 6, 2026, 5:32 AMTanya Rawat
Context Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move
Context Therapeutics stock fell after hours as Q2 loss widened and the company prioritized its pipeline.
Read original at benzinga
CNTX
BenzingaAug 5, 2026, 10:04 PMBenzinga Newsdesk
Context Therapeutics Q2 EPS $(0.15) Misses $(0.09) Estimate
Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.09) by 66.67 percent. This is a 66.67 percent decrease over losses of $(0.09) per
Read original at benzinga
CNTX